Quest Diagnostics
DGX
#1092
Rank
โ‚น1.837 T
Marketcap
โ‚น16,428
Share price
-0.85%
Change (1 day)
22.77%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น574.12 Billion

According to Quest Diagnostics 's latest financial reports the company's total debt is โ‚น574.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Quest Diagnostics - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น607.96 B32.83%
2023-12-31โ‚น457.70 B17.33%
2022-12-31โ‚น390.08 B9.8%
2021-12-31โ‚น355.26 B1.03%
2020-12-31โ‚น351.62 B-8.96%
2019-12-31โ‚น386.22 B38.4%
2018-12-31โ‚น279.06 B13.37%
2017-12-31โ‚น246.14 B-3.77%
2016-12-31โ‚น255.78 B5.42%
2015-12-31โ‚น242.62 B2.31%
2014-12-31โ‚น237.16 B15.21%
2013-12-31โ‚น205.85 B11.76%
2012-12-31โ‚น184.18 B-13.49%
2011-12-31โ‚น212.91 B58.91%
2010-12-31โ‚น133.98 B-7.07%
2009-12-31โ‚น144.17 B-2.71%
2008-12-31โ‚น148.19 B6.65%
2007-12-31โ‚น138.95 B101.64%
2006-12-31โ‚น68.91 B-3.82%
2005-12-31โ‚น71.65 B50.56%
2004-12-31โ‚น47.58 B-5.21%
2003-12-31โ‚น50.20 B27.28%
2002-12-31โ‚น39.44 B-0.52%
2001-12-31โ‚น39.65 B-17.21%
2000-12-31โ‚น47.89 B-9.47%
1999-12-31โ‚น52.90 B167.67%
1998-12-31โ‚น19.76 B-2.31%
1997-12-31โ‚น20.23 B5.04%
1996-12-31โ‚น19.26 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
LabCorp
LH
โ‚น587.42 B 2.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚น0.10 B-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น36.91 B-93.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น0.27 B-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น191.36 B-66.67%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands